Analyst Reco. Insulet Corporation

Equities

PODD

US45784P1012

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
167.2 ^USD	-0.01%		+0.60%	-22.92%

Mar. 20	US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	MT
Mar. 20	Insulet Names Ana Maria Chadwick Finance Chief	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Trims Insulet Price Target to $213 From $214, Maintains Equal Weight Rating	Feb. 26	MT
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking...	Feb. 05
UBS Raises Insulet Price Target to $211 From $175, Maintains Neutral Rating	Jan. 22	MT
Baird Upgrades Insulet to Outperform From Neutral, Raises Price Target to $238 From $180	Dec. 21	MT
ANALYST RECOMMENDATIONS : Amgen, Eli Lilly, Micron Salesforce, Texas Instruments...	Dec. 21
Morgan Stanley Upgrades Insulet to Overweight From Equalweight, Raises Price Target to $234 From $185	Dec. 04	MT
ANALYST RECOMMENDATIONS : Adobe, Broadcom, Comcast, Fair Isaac, Salesforce...	Dec. 04
ANALYST RECOMMENDATIONS : Boeing, Datadog, Estee Lauder, Qualcomm, Snowflake...	Nov. 28
ANALYST RECOMMENDATIONS : Apple, ADP, Fortinet, General Motors, S&P...	Nov. 03
BofA Slashes Price Target on Insulet to $180 From $295, Keeps Buy Rating	23-10-18	MT
Out with the old	23-10-02
Jefferies Upgrades Insulet to Buy From Hold	23-10-02	MT
ANALYST RECOMMENDATIONS : Amgen, Best Buy, Comcast, Fedex, Mosaic...	23-10-02
Morgan Stanley Adjusts Price Target on Insulet to $185 From $208, Maintains Equal-Weight Rating	23-09-29	MT
Raymond James Cuts Insulet Price Target to $228 From $299, Maintains Outperform Rating	23-09-15	MT
UBS Adjusts Insulet Price Target to $215 From $270, Maintains Neutral Rating	23-09-06	MT
BofA Securities Adjusts Insulet's Price Target to $295 From $365, Keeps Buy Rating	23-08-24	MT
Morgan Stanley Adjusts Price Target on Insulet to $208 From $343, Maintains Equalweight Rating	23-08-24	MT
Citigroup Upgrades Insulet to Buy From Neutral, Adjusts Price Target to $265 From $273	23-08-21	MT
Baird Downgrades Insulet to Neutral From Outperform, Adjusts Price Target to $219 From $320	23-08-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Insulet Corporation

Equities

PODD

US45784P1012

Analyst Reco.

Filters